MolClaw: An Autonomous Agent with Hierarchical Skills for Drug Molecule Evaluation, Screening, and Optimization
Not on the map. Why?
Abstract (arXiv)
Computational drug discovery, particularly the complex workflows of drug molecule screening and optimization, requires orchestrating dozens of specialized tools in multi-step workflows, yet current AI agents struggle to maintain robust performance and consistently underperform in these high-complexity scenarios. Here we present MolClaw, an autonomous agent that leads drug molecule evaluation, screening, and optimization. It unifies over 30 specialized domain resources through a three-tier hierarchical skill architecture (70 skills in total) that facilitates agent long-term interaction at runtime: tool-level skills standardize atomic operations, workflow-level skills compose them into validated pipelines with quality check and reflection, and a discipline-level skill supplies scientific principles governing planning and verification across all scenarios in the field. Additionally, we introduce MolBench, a benchmark comprising molecular screening, optimization, and end-to-end discovery challenges spanning 8 to 50+ sequential tool calls. MolClaw achieves state-of-the-art performance across all metrics, and ablation studies confirm that gains concentrate on tasks that demand structured workflows while vanishing on those solvable with ad hoc scripting, establishing workflow orchestration competence as the primary capability bottleneck for AI-driven drug discovery.
Key facts. Cited by 7 papers in the map (data through 14 Oct 2026). Builds on 17 of its 68 references that are in the map. First posted on arXiv 2 Apr 2026.
Builds on
17 of 68 references.
References · 17
- 2023GPT-4 Technical Reportcited by 18,396
- 2023LLaMA: Open and Efficient Foundation Language Modelscited by 14,132
- 2022ReAct: Synergizing Reasoning and Acting in Language Modelscited by 8,695
- 2023Toolformer: Language Models Can Teach Themselves to Use Toolscited by 4,182
- 2023Qwen Technical Reportcited by 3,344
- 2023ChemCrow: Augmenting large-language models with chemistry toolscited by 631
- 2023Augmented Language Models: a Surveycited by 403
- 2022DiffDock: Diffusion Steps, Twists, and Turns for Molecular Dockingcited by 313
- 2024Empowering Biomedical Discovery with AI Agentscited by 118
- 2025TxAgent: An AI Agent for Therapeutic Reasoning Across a Universe of Toolscited by 59
- 2025Beyond Chemical QA: Evaluating LLM's Chemical Reasoning with Modular Chemical Operationscited by 49
- 2024DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaborationcited by 44
5 more
- 2026InternAgent-1.5: A Unified Agentic Framework for Long-Horizon Autonomous Scientific Discoverycited by 27
- 2025LIDDIA: Language-based Intelligent Drug Discovery Agentcited by 24
- 2023Activity Cliff Prediction: Dataset and Benchmarkcited by 11
- 2025SCP: Accelerating Discovery with a Global Web of Autonomous Scientific Agentscited by 6
- 2026Mozi: Governed Autonomy for Drug Discovery LLM Agentscited by 5
Built on by
Citing papers per year: 2026: 7.
7 papers.
- 2026Scaling the Horizon, Not the Parameters: Reaching Trillion-Parameter Performance with a 35B Agentcited by 22
- 2026Harnessing AtomisticSkills for Agentic Atomistic Researchcited by 6
- 2026SKT: Skill-Use Training at Scale via Verified Synthetic Data Generationcited by 3
- 2026CAi Copilot: Reducing Operational Workload in Molecular Design through Intent-Driven Agentic Workflowscited by 1
- 2026Evaluating Agentic Harness Systems for Autonomous Computational Pathologycited by 0
- 2026Evaluating Agentic Bioinformatics through Function, Evidence, and Validationcited by 0
- 2026Designing a Robust LLM-Based Evaluation System for Agentic AI in Drug Discovery Through Human Alignmentcited by 0
- 2026Designing a Robust LLM-Based Evaluation System for Agentic AI in Drug Discovery Through Human Alignment21 Aug 2026
- 2026CAi Copilot: Reducing Operational Workload in Molecular Design through Intent-Driven Agentic Workflows7 Aug 2026
- 2026SKT: Skill-Use Training at Scale via Verified Synthetic Data Generation3 Aug 2026
- 2026Evaluating Agentic Bioinformatics through Function, Evidence, and Validation30 Jul 2026
- 2026Evaluating Agentic Harness Systems for Autonomous Computational Pathology1 Jul 2026
- 2026Scaling the Horizon, Not the Parameters: Reaching Trillion-Parameter Performance with a 35B Agent29 Jun 2026
- 2026Harnessing AtomisticSkills for Agentic Atomistic Research18 May 2026